Antiangiogenic VEGF-A in peripheral artery disease

Nature Medicine

Volumn 20, Issue 12, 2014, Pages 1383-1385

  Boucher, Joshua M ^a   Bautch, Victoria L ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN A; WNT5A PROTEIN;

ALTERNATIVE RNA SPLICING; ANTIANGIOGENIC ACTIVITY; HUMAN; LIMB ISCHEMIA; MUSCLE ISCHEMIA; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHORT SURVEY; ANGIOGENESIS; ANIMAL; METABOLISM; PHYSIOLOGY;

ANIMALS; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; PERIPHERAL ARTERIAL DISEASE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84923540931     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.3767     Document Type: Short Survey

References (15)

1. Annex, B. H. Nat. Rev. Cardiol. 10, 387-396 (2013).
2. Kikuchi, R. et al. Nat. Med. 20, 1464-1471 (2014).
3. Shimamura, M., Nakagami, H., Koriyama, H., Morishita, R. Biomed. Res. Int. 2013, 186215 (2013).
4. Makin, A. J., Chung, N. A. Y., Silverman, S. H., Lip, G. Y. H. Clin. Sci. 104, 397-404 (2003).
5. Bates, D. O. et al. Cancer Res. 62, 4123-4131 (2002).
6. Peiris-Pagès, M. Cell Adh. Migr. 6, 561-568 (2012).
7. Volpi, N. et al. Mediators Inflamm. 2013, 219313 (2013).
8. Jones, W. S. et al. Vasc. Med. 17, 94-100 (2012).
9. Kikuchi, A., Yamamoto, H., Sato, A., Matsumoto, S. Acta Physiol. (Oxf. ) 204, 17-33 (2012).
10. Stefater, J. A. III et al. Nature 474, 511-515 (2011).
11. Ouchi, N. et al. Science 329, 454-457 (2010).
12. Merdzhanova, G. et al. Oncogene 29, 5392-5403 (2010).
13. Rieder, D. et al. Cell. Mol. Life Sci. 71, 1741-1759 (2014).
14. Yoshida, K. et al. Nature 478, 64-69 (2011).
15. Nowak, D. G. et al. J. Cell Sci. 121, 3487-3495 (2008).